PSMC2 promotes glioma progression by regulating immune microenvironment and PI3K/AKT/mTOR pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PSMC2 promotes glioma progression by regulating immune microenvironment and PI3K/AKT/mTOR pathway

Published:2024-05 Issue:3 Volume:229 Page:152802
ISSN:0171-2985
Container-title:Immunobiology
language:en
Short-container-title:Immunobiology

Author:

Wang Yizheng,Zhang Shiyang,Zhao Zijun,Jin Qianxu,Wang Zairan,Song Zihan,Liu Liqiang,Zhao Zongmao

Funder

Natural Science Foundation of Hebei Province

Publisher

Elsevier BV

Reference33 articles.

1. Immune checkpoint blockade in hematologic malignancies;Armand;Blood,2015

2. Wnt and PI3K/Akt/mTOR survival pathways as therapeutic Targets in glioblastoma;Barzegar Behrooz;Int. J. Mol. Sci.,2022

3. Immune checkpoint inhibitors in melanoma;Carlino;Lancet,2021

4. Identification of diverse tumor endothelial cell populations in malignant glioma;Carlson;Neuro Oncol.,2021

5. Silencing of PSMC2 inhibits development and metastasis of prostate cancer through regulating proliferation, apoptosis and migration;Chen;Cancer Cell Int.,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP